We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

Ribometrix, a spinout of UNC-Chapel Hill, has named William Marshall as its new CEO, succeeding former chief executive ...

Friday announced that the U.S. Food and Drug Administration has approved its Lumakras plus Vectibix combination ...

THOUSAND OAKS, Calif. - Amgen (NASDAQ:AMGN), a prominent biotechnology company with a market capitalization of $144.8 billion, has received FDA approval for LUMAKRAS® (sotorasib) in combination with ...

We hoped industry layoffs would relent in 2024. That's not what happened. | As always, if you know of layoffs occurring at a ...

Central Coast nonprofits and companies are stepping up to support those impacted by the devastating Los Angeles County wildfires. Thousand Oaks-based biotech giant Amgen announced Jan. 14 that it and ...

Some investors believe you make money when you buy a stock, not when you sell it. The logic behind this idea is that ...

Jefferies analyst Michael Yee maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $350.00. The company’s ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in ...

Hinge Bio is committed to developing life-changing medicines for patients with intractable diseases,” said Chief Executive Officer Barry Selick, Ph.D. “These funds will enable early clinical ...

The first group of apprentices has officially signed on with Amgen in a unique program that will prepare a skilled workforce ...

CytomX Therapeutics, a Bay Area biotech firm with lucrative and high-profile partnerships in the industry, is laying off 40% ...